Category: Main > CPD Providers and Courses > CPD Courses

Oncology CPD with the Webinar Vet  - £0.00 Listing ID: 2651

Classified Auction Info

Listing Began: Tuesday, February 4, 2020


Further information:

Below are just some of the webinars available to our members or can be purchased individually

For more information on our courses and membership please visit our shopfront


Tricks of the trade-tools to help nail the cancer diagnosis

Sophia Tzannes

This webinar will approach the diagnosis of different cancers and how best to maximise your chances of a successful investigation, using case-based examples. From the basics of in-house cytology, to identifying when we should ask pathologists for more, and what should we ask for. Understanding the tools available helps us not only manage the more challenging cases but can assist with treatment choices.

Sophia Tzannes is a graduate from the University of Sydney in Australia. Following four years in private practice, both in Australia and the UK, she completed her residency in internal medicine at the University of Liverpool and continued working in the clinic in the internal medicine and oncology departments.  Sophia returned to Sydney in 2008 to work in private referral practice (Small Animal Specialist Hospital). Her main interests are haematology, immunology and oncology. She is a Diplomate of the European College of Veterinary Internal Medicine.


Lymphoma in cats and dogs. Which protocol?

Shasta Lynch

Shasta Lynch will discuss Lymphoma in cats and dogs. Which protocol? With so many options for treating lymphoma in cats and dogs it can be difficult to know what the most effective treatment options are and to balance this with the practicalities of treating cancer in veterinary patients. Join us to discuss new treatment options, options for treatment in general practice and how we can help you to manage your lymphoma patients more comfortably.

After graduating from the University of Queensland, Australia in 2004, Shasta spent 4 years in Australia in general practice, emergency practice and as an intern. She then moved to the UK and completed a residency in Small Animal Oncology. She is eligible for the ECVIM specialist examinations in Oncology in 2014.


Safe Use of Chemotherapy in practice

Neil Palmer

Neil will discuss chemotherapy in general practice, safe use and applications. Neil graduated from Liverpool University in 1987 and following a period in mixed practice has spent the last 15 years in small animal practice in Bradford. He joined the Veterinary Team at Abbey House in November 2009. He has a particular interest in oncology cases and is currently working towards gaining his Masters degree in clinical oncology. Neil’s main interest is in surgical oncology and adjuvant therapies, pain management and palliative care.


Receptor Tyrosine Kinases and Animal Cancer: Palladia, Masivet and Beyond

Douglas H. Thamm

Receptor tyrosine kinases (RTKs), cell signaling molecules on the surface of cancer cells, are some of the most common targets for new human cancer therapeutics. Recently, 2 RTK inhibiting drugs, Palladia and Masivet (Kinavet), have been approved for the treatment of canine mast cell tumours, and more may be on the way. This hour will discuss the biology and function of RTKs, what is known about their importance in canine cancer, and the data regarding safety and effectiveness of Palladia and Kinavet in canine mast cell tumours and other neoplasia. Strategies for the monitoring of patients receiving these medications and ongoing evaluations will be discussed in detail.

 Dr. Thamm is an Associate Professor and Barbara Cox Anthony Chair in Oncology and at the Colorado State University Animal Cancer Center.  He is also a member of the Developmental Therapeutics Section of the University of Colorado Comprehensive Cancer Center and the Cell and Molecular Biology Graduate Program at Colorado State University.  Dr. Thamm received his Bachelor’s and V.M.D. degrees from the University of Pennsylvania.  He completed a Residency in Medical Oncology at the University of Wisconsin, and was a researcher there for 5 additional years before joining the faculty at CSU in 2004.  He is the author of over 80 peer-reviewed publications in veterinary and basic cancer research, was Oncology Section Editor for the 2 most recent editions of Kirk’s Veterinary Therapy and is Co-Editor-In-Chief of the journal Veterinary and Comparative Oncology.  His clinical and research interests include novel targeted therapies for animal and human cancer and ways to integrate these therapies with existing treatment.


Pet Cancer Myths: managing owners’ expectations

Dr Chiara Penzo

Clinical oncology is as much about increasing awareness as treating cancer in pets. Cancer is an emotive disease because of its potential life-threatening nature, and counseling skills are essential when dealing with upset and worried owners. This is complicated by having to dispel diffuse negative preconceived notions about the disease and its treatment that may prevent pets from receiving effective and worthwhile options for care. Many owners may refuse to pursue treatment, or delay a decision to opt for anti-cancer treatment, when they are not appropriately informed. By wrongly comparing treatment for their pet with anti-cancer treatment in people, they may believe that their pet will suffer severe side effects, and that treatment represents a selfish choice rather than one made in their pet’s best interest.
Dr Chiara Penzo will address the most frequently asked questions by owners of pets with cancer to help to increase awareness and fight the most diffuse stigmas attached to the diagnosis and treatment of cancer in pets. She will discuss from the owners’ point of view topics such as quality of life, survival statistics, adverse effects from anticancer therapy, health and safety & use of social media as a practice tool of owner support. Helping the owners to have a better understanding can ensure that they make an informed decision when selecting diagnostic tests and treatments. Delegates will take away practical information to assist clients in making the best decision for themselves and their pet.


Update on Canine Osteosarcoma

Douglas H. Thamm, VMD, DACVIM (Oncology)

Update on Canine Osteosarcoma, this webinar is presented by Douglas H. Thamm, VMD, DACVIM (Oncology)
Associate Professor and Barbara Cox Anthony Chair in Oncology.


A Practitioner’s Guide to Canine Lymphoma

Douglas H. Thamm, VMD, DACVIM (Oncology)

Lymphoma is one of the most common cancers encountered in small animal veterinary practice, and can be one of the most gratifying to treat, owing to the very high response rate with chemotherapy. This hour will discuss the basics of diagnosing and staging canine lymphoma, treatment options, and new findings and controversies regarding lymphoma diagnosis and therapy.  Lymphoma can be treated by the general practitioner!


An Update on Mast Cell Tumours

David Argyle

Mast Cell Tumours


Public Questions / Answers

No questions have been posted about this listing.

Contact us to advertise here

<< Previous Next >>